Today’s sentencing concludes the UK’s first successful prosecution of a manufacturer for knowingly providing falsified data to the MHRA in order to obtain a Marketing Authorisation.
Kamlesh Vaghjiani, former director of pharmaceutical company Kappin Ltd, was sentenced to eight and seven months on two counts, to run concurrently, both suspended for 18 months, at Southwark Crown Court, London following investigations by the Medicines and Healthcare products Regulatory Agency (MHRA) into Kappin’s product, Evotrox Oral Solution.
Vaghjiani and Kappin Ltd were both individually fined £50,000, having previously paid a confiscation order of £1,075,589.88, reflecting Kappin Limited’s profit from the crime. Kappin Ltd was also ordered to pay prosecution costs of £82,262.20…
